Literature DB >> 27502360

Immunotherapy: Here or there, PD-L1 can be anywhere.

Diana Romero.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27502360     DOI： 10.1038/nrclinonc.2016.129

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma.

Authors:  Hiroaki Miyoshi; Junichi Kiyasu; Takeharu Kato; Noriaki Yoshida; Joji Shimono; Shintaro Yokoyama; Hiroaki Taniguchi; Yuya Sasaki; Daisuke Kurita; Keisuke Kawamoto; Koji Kato; Yoshitaka Imaizumi; Masao Seto; Koichi Ohshima
Journal:  Blood       Date:  2016-07-14       Impact factor: 22.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.